Arthur J. Gallagher & Co.

AJG

AJ Garner is a prominent global insurance brokerage and consulting firm.
It serves a diverse client base by providing comprehensive risk management and employee benefits solutions.

$218.37 +3.88 (+1.81%)

Updated: February 19, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy AJG Today?

Based on the provided data, here is a comprehensive analysis of Arthur J. Gallagher & Co. (AJG).

Technical Analysis AJG is experiencing significant technical weakness, having declined sharply over one and three-month periods. While the stock is not at an extreme oversold level, sitting in the lower-middle portion of its 52-week range, the severity of its recent underperformance is concerning given its historically low volatility.

Fundamental Analysis Fundamentally, the picture is mixed but carries notable red flags. While Q4 revenue showed sequential growth, profitability metrics deteriorated sharply, with net profit margin and gross profit ratio falling significantly. Operational efficiency is weak, as indicated by a very low ROE and a high days sales outstanding, though the company's debt levels remain reasonable.

Valuation Valuation metrics suggest the stock is significantly overvalued. The extremely high forward P/E of 111.5 and a negative PEG ratio point to anticipated earnings compression. The exceptionally high EV/EBITDA ratio further indicates that the company's enterprise value is not well-supported by its current operating profitability.

Risk Assessment AJG's low beta suggests lower volatility than the market, which is a positive. However, this is offset by the substantial 41% maximum drawdown, indicating a real risk of significant capital loss. The lack of high short interest suggests the market is not overwhelmingly bearish, but operational risks are evident.

**Recommendation: HOLD**

Based on this analysis, a buy recommendation is not warranted at this time. The combination of weak price momentum, deteriorating profitability, and significantly high valuation multiples presents substantial headwinds. While the company's reasonable debt level offers some stability, investors should wait for clearer signs of improved operational efficiency and earnings stability before considering a position. This is not investment advice, for reference only.

CTA Banner

AJG 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, here is a 12-month outlook for Arthur J. Gallagher & Co. (AJG):

The primary catalysts for a potential rebound will be a demonstrated improvement in operational efficiency and a stabilization of profit margins in upcoming quarterly reports, which could help justify its premium valuation. Key risks include the continuation of earnings compression, failure to address the high days sales outstanding, and the possibility of further multiple contraction given the stock's significant overvaluation based on forward P/E and EV/EBITDA ratios. In the absence of a clear analyst target price, the outlook is cautious; investors should monitor for a break above recent resistance levels for a more bullish stance, but the current technical weakness and fundamental headwinds suggest a neutral to slightly negative bias, with the stock likely to trade in a wide range as it searches for a sustainable valuation floor. A prudent course is to maintain a HOLD rating until fundamentals show clearer signs of improvement.

Wall Street Consensus

Most Wall Street analysts are optimistic about Arthur J. Gallagher & Co.'s 12-month outlook, with consensus target around $218.37, indicating expected upside potential.

Average Target
$218.37
21 analysts
Implied Upside
+0%
vs. current price
Analyst Count
21
covering this stock
Price Range
$175 - $284
Analyst target range
Buy Buy
10 (48%)
Hold Hold
10 (48%)
Sell Sell
1 (5%)

Bulls vs Bears: AJG Investment Factors

Overall, AJG has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Morgan Stanley Overweight Rating: New coverage with $300 price target signals strong institutional confidence.
  • Strategic Acquisitions: Recent purchases of B&W Insurance and First Actuarial expand market presence.
  • Analyst Bullish Outlook: Many analysts remain positive despite recent underperformance versus S&P 500.
Bearish Bearish
  • Insider Selling Trend: More insider selling than buying in recent months raises concerns.
  • AI Disintermediation Fears: Stock dropped on concerns AI could disrupt traditional brokerage models.
  • Recent Price Weakness: Stock has significantly underperformed S&P 500 over the past year.
  • Truist Price Target Cut: Price target lowered to $280, reflecting some analyst caution.
Reward Banner

AJG Technical Analysis

AJG has delivered notably weak price performance, declining significantly over recent months amid substantial underperformance relative to the broader market.

The stock has declined sharply over both one-month (-14.32%) and three-month (-14.94%) periods, substantially underperforming the market by -16.79% over the latter span. This pronounced weakness is particularly striking given the stock's historically low beta, indicating the decline is more severe than its typical volatility profile would suggest.

Currently trading at $218.37, AJG sits approximately 38% above its 52-week low but remains 38% below its annual high, positioning it in the lower-middle portion of its yearly range. While significantly off its peak—reflected in the substantial 41% maximum drawdown—the stock does not appear to be at an extreme oversold level given this intermediate positioning.

📊 Beta
0.66
0.66x market volatility
📉 Max Drawdown
-41.3%
Largest decline past year
📈 52-Week Range
$195-$351
Price range past year
💹 Annual Return
-32.8%
Cumulative gain past year
Period AJG Return S&P 500
1m -14.3% +1.0%
3m -14.9% +1.9%
6m -24.9% +6.5%
1y -32.8% +12.1%
ytd -14.7% +0.2%

AJG Fundamental Analysis

Revenue & Profitability AJG's Q4 2025 revenue of $3.63 billion shows sequential growth from Q3's $3.37 billion. However, profitability metrics weakened significantly, with net profit margin declining from 8.1% to 4.2% quarter-over-quarter, reflecting considerable margin pressure despite revenue growth. The gross profit ratio dropped sharply from 90.6% to 39.1%, indicating meaningful changes in cost structure or reporting methodology.

Financial Health The company maintains a reasonable debt level with a debt-to-equity ratio of 0.60 and a conservative debt ratio of 19.8%. However, the interest coverage ratio of 2.1 appears tight, suggesting limited buffer for servicing debt obligations from operating earnings. The current ratio of 1.06 indicates adequate short-term liquidity, though cash ratios remain low at just 0.04.

Operational Efficiency AJG demonstrates weak operational efficiency with an ROE of just 0.65% and ROA of 0.21%, reflecting minimal returns on capital employed. The asset turnover ratio of 0.05 indicates poor utilization of the company's asset base to generate revenue. The high days sales outstanding of 128 days suggests extended collection periods, potentially impacting working capital management.

Quarterly Revenue
$3.6B
2025-12
Revenue YoY Growth
+33.6%
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
$-13.9B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is AJG Overvalued?

Valuation Level: The stock appears significantly overvalued based on its traditional earnings metrics. The trailing PE of 36.7 is high for an insurance broker, and this is compounded by an extremely elevated forward PE of 111.5, which suggests anticipated earnings compression. Further supporting this view are a deeply negative PEG ratio, indicating negative growth expectations relative to the high PE, and an exceptionally high EV/EBITDA of 113.8, signaling that the company's enterprise value is not well-supported by its operating profitability.

Peer Comparison: A formal peer comparison cannot be performed due to the lack of provided industry average data. However, given the metrics presented, these valuation multiples would typically be considered outliers in the financial services or insurance brokerage sector, where earnings-based valuations are generally more moderate. For a conclusive assessment, a direct comparison against the PE, PB, and EV/EBITDA ratios of comparable companies would be required.

PE
36.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -378×-112×
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
113.8x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: AJG's beta of 0.658 indicates significantly lower volatility than the broader market, suggesting muted risk from general market swings. However, the substantial 1-year maximum drawdown of -41.28% reveals the stock has experienced periods of severe price depreciation, highlighting a material risk of capital loss despite its low beta.

Other Risks: The absence of any significant short interest suggests the market does not anticipate substantial near-term downside pressure or hold a bearish consensus on the stock. Investors should, however, remain mindful of company-specific operational or industry-wide risks that are not captured by this metric.

FAQs

Is AJG a good stock to buy?

Based on the analysis, I maintain a neutral-to-cautious stance on AJG. The stock appears significantly overvalued with a forward P/E of 111.5 and weak operational metrics (low ROE/ROA), which are substantial headwinds. While strategic acquisitions provide a long-term growth angle, near-term pressure from margin compression and AI disruption fears persist. This stock may suit only highly patient, long-term investors who believe in the company's acquisition strategy and can tolerate its rich valuation and operational challenges.

Is AJG stock overvalued or undervalued?

Based on the provided metrics, AJG stock appears significantly overvalued. Its trailing P/E of 36.7 and exceptionally high forward P/E of 111.5 are extreme outliers, especially when benchmarked against typical valuations for insurance brokers which are generally more moderate. The deeply negative PEG ratio of -2.46 confirms that its high price is not justified by growth expectations, which are, in fact, negative. This overvaluation is primarily driven by a sharp decline in profitability, as evidenced by a collapsing net profit margin and very poor returns on equity and assets, indicating the company's earnings power does not support its current market price.

What are the main risks of holding AJG?

Based on the provided information, here are the key risks of holding AJG stock, ordered by importance:

1. Severe Profitability and Margin Compression: Despite sequential revenue growth, the company is experiencing a severe and rapid deterioration in profitability, as evidenced by the net profit margin halving and the gross profit ratio collapsing from 90.6% to 39.1% in the latest quarter. 2. Weak Operational Efficiency and Poor Capital Returns: The company demonstrates fundamentally weak operations, with very low returns on equity (0.65%) and assets (0.21%), coupled with poor asset turnover (0.05), indicating an inability to generate sufficient profits from its capital base. 3. Tight Interest Coverage and Liquidity Constraints: AJG's ability to service its debt is a concern, as its interest coverage ratio of 2.1 provides a very slim buffer, while extremely low cash ratios (0.04) indicate limited financial flexibility.

What is the price forecast for AJG in 2026?

Based on the provided analysis, my forecast for AJG stock towards the end of 2026 is cautious, projecting a base case target price range of $210-$240 and a bull case of $260-$280, contingent on a successful operational turnaround.

Key growth drivers needed are a significant improvement in operational efficiency (specifically reducing the 128-day sales outstanding) and a stabilization or recovery of profit margins from their current depressed levels. The main assumptions are that management can effectively address the current margin compression and that the premium valuation multiple does not contract further. Given the significant uncertainties highlighted by weak current fundamentals and the stock's high valuation, this forecast is highly sensitive to the company's upcoming quarterly results demonstrating tangible improvement.